Your browser doesn't support javascript.
loading
Inhibition of EZH2 exerts antitumorigenic effects in renal cell carcinoma via LATS1.
Hong, Seong Hwi; Hwang, Hyun Ji; Son, Da Hyeon; Kim, Eun Song; Park, Sung Yul; Yoon, Young Eun.
Afiliação
  • Hong SH; Department of Urology, Hanyang University College of Medicine, Seoul, Korea.
  • Hwang HJ; Department of Urology, Hanyang University College of Medicine, Seoul, Korea.
  • Son DH; Department of Translational Medicine, Hanyang University Graduate School of Biomedical Science & Engineering, Seoul, Korea.
  • Kim ES; Department of Urology, Hanyang University College of Medicine, Seoul, Korea.
  • Park SY; Department of Translational Medicine, Hanyang University Graduate School of Biomedical Science & Engineering, Seoul, Korea.
  • Yoon YE; Department of Urology, Hanyang University College of Medicine, Seoul, Korea.
FEBS Open Bio ; 13(4): 724-735, 2023 04.
Article em En | MEDLINE | ID: mdl-36808829

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Tipo de estudo: Prognostic_studies Limite: Adult / Humans Idioma: En Revista: FEBS Open Bio Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Tipo de estudo: Prognostic_studies Limite: Adult / Humans Idioma: En Revista: FEBS Open Bio Ano de publicação: 2023 Tipo de documento: Article